Eric Lefkofsky is the CEO of Tempus. He announced that the company had entered into a partnership with the University of Chicago. The company will work with doctors at the University to help them treat breast cancer patients better. Breast cancer specialists at the institution will get access to molecular sequencing and analysis tools that will aid in developing personalized treatment plans. The company will sift through data from thousands of breast cancer patients to come up with predictions about the response that the patients will have to the treatment.
The goal is that the data will help to find better treatment methods and outcomes for the patient. Dr. Olopade is the dean of Global Health at the University. He said that there is little available data on patients that have battled breast cancer. This is alarming because breast cancer is one of the most common types of cancer. He said that this makes it hard for physicians to make decisions because they do not have access to detailed genetic information. He added that this hinders them from making targeted and informed treatment decisions. He finished by saying that he was excited by the opportunity for the university to work together with Tempus.
Lefkofsky is one of the founders of Groupon. He served as its Chairman until last year. He is also the co-founder of various companies including Uptake Technologies, Mediaocean, Echo Global Logistics, and InnerWorkings. Lefkofsky was responsible for the success of these enterprises. Lefkofsky started the Lefkofsky Family Foundation with his wife in 2006. The foundation supports initiatives that seek to improve the quality of life and the communities that they serve. He is a Trustee of The Museum of Science and Industry, The Art Institute of Chicago, and the Lurie Children’s Hospital. Lefkofsky attended the University of Michigan where he earned his Bachelor’s degree, and J.D. Lefkofsky is an author. His book known as Accelerated Disruption was released a few months ago.